Wednesday, May 17, 2006 10:30:55 AM
U.S. State Department Submits Second Order for IDenta Drug Detection Products
May 17, 2006 10:23:00 AM
JERUSALEM, May 17 /PRNewswire-FirstCall/ -- IDenta Corp. (OTC Pink Sheets: IDTA - News) announced today that it has received its second order from the U.S. Department of State. The transaction was completed through its U.S. representative, Millennium Security Solutions (MSS). This is the second order for IDenta's drug detection products from the State Department in the last 30 days, and is reported to be substantially larger than the first contract.
"We are building confidence in two significant areas with the Federal Government," explained Michael Phipps, CEO of Millennium Security Solutions (MSS). "First we had to build the confidence that IDenta's products could do the job in the field, and by receiving this order in such a short period of time, we know the products are performing exactly as represented. Second, we are building confidence in IDenta's ability to deliver significant orders within the agreed timeframe. We have been assured by IDenta executives that these size orders are well within their current production and delivery capabilities."
This State Department order is believed to be headed for an unnamed country in southeast Asia. The first order was destined for Central America. There are no firm estimates of the total U.S. government expenditures on drug detection products such as IDenta's, but is expected to exceed $50 million per year.
About Millennium Security
Millennium Security Solutions, headquartered in McLean, Virginia develops unique security solutions for all levels of government, corporations and educational institutions. MSS focuses on proven state of the art technology with expert integration in order to solve our customer's specific needs.
Millennium has also begun to provide sample kits to qualified individuals, businesses and industry and public media in the consumer, civilian, and governmental marketplaces who believe the kits may be beneficial to their organizations. For further information please call 703-752-3755 to submit a request for samples. http://www.millss.com
About IDenta
IDenta Corporation is one of the world's leading providers of proprietary on-site drug detection kits for governmental, professional and civilian use. Information concerning IDenta's business plan and product line, including rapid test kits (substance only) for the detection of marijuana, hashish, ecstasy, cocaine, crack, heroin and methamphetamines may be found at http://www.IDenta.biz and http://www.drugsdetector.com
IDenta and Millennium support "D.A.M.M.A.D.D.," Dads and Mad Moms Against Drug Dealers, (http://www.dammadd.org )
For Investor Relations, lobbying interests or information concerning
IDenta's products internationally contact:
Yaacov Shoham, IDenta Corp., CEO
Tel: +972-52-6554487, +972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com
For Investor Relations in the United States contact:
Randy Jacobs, SITCOM LLC
IDentaNews@sitcomllc.com
+1-800-316-9437
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
SOURCE IDenta Corp.
----------------------------------------------
For Investor Relations
lobbying interests or information concerning IDenta's products internationally contact: Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
+972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com. For Investor Relations in the United States contact: Randy Jacobs
SITCOM LLC
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM